BioAdaptives (BDPT) Stock Statistics & Valuation Metrics

BioAdaptives has a market cap or net worth of $904.87K. The enterprise value is $1.25M.

BioAdaptives has 9,048,659 shares outstanding. The number of shares has decreased by -2.65% in one year.

BioAdaptives’s return on equity (ROE) is 0.61 and return on invested capital (ROIC) is 53.39%.

The current PE Ratio of BioAdaptives is -54.82. BioAdaptives’s PEG ratio is <0.01.

In the last 12 months, BioAdaptives had revenue of 12.67K and earned -899.16K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -306.24K and capital expenditures 0.00, giving a free cash flow of -306.24K billion.

BioAdaptives pays an annual dividend of ―, resulting in a dividend yield of ―

BioAdaptives upcoming earnings date is ―, TBA Not Confirmed.

BioAdaptives as a current ratio of 0.15, with Debt / Equity ratio of -21.84%

In the past 12 months, BioAdaptives has paid -5.60K in taxes.

BioAdaptives EV to EBITDA ratio is -82.21, with an EV/FCF ratio of -198.38.

BioAdaptives has $39.56K in cash and marketable securities with $343.10K in debt, giving a net cash position of $303.53K billion.

Gross margin is 5.84%, with operating margin of -4752.47%, and net profit margin of -7097.33%.

The average price target for BioAdaptives is ―, which is 11.43% higher than the current price. The consensus rating is ―